IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
418.11
-5.49 (-1.30%)
Mar 25, 2025, 4:00 PM EST - Market closed
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$354,319
Profits / Employee
$80,715
Market Cap
33.97B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11,000 | 0 | - |
Dec 31, 2023 | 11,000 | 220 | 2.04% |
Dec 31, 2022 | 10,780 | 430 | 4.15% |
Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
Dec 31, 2020 | 9,300 | 100 | 1.09% |
Dec 31, 2019 | 9,200 | 823 | 9.82% |
Dec 31, 2018 | 8,377 | 777 | 10.22% |
Dec 31, 2017 | 7,600 | 235 | 3.19% |
Dec 31, 2016 | 7,365 | 565 | 8.31% |
Dec 31, 2015 | 6,800 | 400 | 6.25% |
Dec 31, 2014 | 6,400 | 700 | 12.28% |
Dec 31, 2013 | 5,700 | 300 | 5.56% |
Dec 31, 2012 | 5,400 | 300 | 5.88% |
Dec 31, 2011 | 5,100 | 300 | 6.25% |
Dec 31, 2010 | 4,800 | 0 | - |
Dec 31, 2009 | 4,800 | 100 | 2.13% |
Dec 31, 2008 | 4,700 | 0 | - |
Dec 31, 2007 | 4,700 | 800 | 20.51% |
Dec 31, 2006 | 3,900 | 600 | 18.18% |
Dec 31, 2005 | 3,300 | 305 | 10.18% |
Dec 31, 2004 | 2,995 | 522 | 21.11% |
Dec 31, 2003 | 2,473 | 292 | 13.39% |
Dec 31, 2002 | 2,181 | 11 | 0.51% |
Dec 31, 2001 | 2,170 | -80 | -3.56% |
Dec 31, 2000 | 2,250 | 200 | 9.76% |
Dec 31, 1999 | 2,050 | -50 | -2.38% |
Dec 31, 1998 | 2,100 | 0 | - |
Dec 31, 1997 | 2,100 | 585 | 38.61% |
Dec 31, 1996 | 1,515 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IDXX News
- 8 days ago - IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy' - Seeking Alpha
- 13 days ago - IDEXX Laboratories: A Top Dog In The Pet Care Market - Seeking Alpha
- 5 weeks ago - IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
- 6 weeks ago - IDEXX Laboratories And Its Real Value - Seeking Alpha
- 6 weeks ago - IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future - Seeking Alpha
- 7 weeks ago - Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers. - Barrons
- 7 weeks ago - IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices - Investopedia